¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"complement fixing antibody"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
complement-fixing antibody
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
anti-idiotype antibody
Ç×À̵ð¿ÀŸÀÔÇ×ü, Ç×°³º°Æ¯ÀÌÇüÇ×ü
antimitochondrial antibody
Ç×¹ÌÅäÄܵ帮¾ÆÇ×ü, Ç׻縳üÇ×ü
antineutrophil cytoplasmic antibody
Ç×Áß¼º±¸¼¼Æ÷ÁúÇ×ü
antinuclear antibody
Ç×ÇÙÇ×ü
antinuclear antibody test
Ç×ÇÙÇ×ü°Ë»ç
antiphospholipid antibody
Ç×ÀÎÁöÁúÇ×ü
anti-Ro antibody
Ç×RoÇ×ü
anti-Sm antibody
Ç×SmÇ×ü
antisperm antibody
Ç×Á¤ÀÚÇ×ü
atypical antibody
ºñÁ¤ÇüÇ×ü
autoimmune antibody
ÀÚ°¡¸é¿ªÇ×ü
autoreactive antibody
ÀÚ°¡¹ÝÀÀÇ×ü
anaphylactic antibody
¾Æ³ªÇʶô½Ã½ºÇ×ü
bivalent antibody
À̰¡Ç×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
antibody-binding site
Ç×ü°áÇÕºÎÀ§
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-mediated hypersensitivity
Ç×ü¸Å°³°ú¹Î
antibody-mediated immunity
Ç×ü¸Å°³¸é¿ª
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-antibody complex
Ç׿øÇ×üº¹ÇÕü
antigen-antibody interaction
Ç׿øÇ×ü¹ÝÀÀ
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
antinuclear antibody test
Ç×ÇÙÇ×ü°Ë»ç
atypical antibody
ÀÌÇüÇ×ü
autoimmune antibody
ÀÚ°¡¸é¿ªÇ×ü
autoreactive antibody
ÀÚ°¡¹ÝÀÀÇ×ü
bivalent antibody
À̰¡Ç×ü
blocking antibody
Â÷´ÜÇ×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
antibody combining site
Ç×ü°áÇÕºÎ(ù÷ô÷Ì¿ùêÝ»).
antibody deficiency syndrome
Ç×ü°áÇÌÁõÈıº(ù÷ô÷ÌÀù¹ñøý¦ÏØ).
antibody dependent cell mediated cytotoxicity
Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
antibody detection
Ç×ü°ËÃâ
antibody diversity
Ç×ü´Ù¾ç¼º.
antibody excess
Ç×ü°úÀ×(ù÷ô÷Φí¥).
antibody excess zone
Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
antibody excess zone
Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
antibody excess zone
Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
antibody feedback mechanism
Ç×üµÇ¸ÔÀ̱â±âÀü.
antibody formation
Ç×üÇü¼º(ù÷ô÷û¡à÷).
antibody forming cell
Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
antibody half-life
Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
antibody identification test
Ç×üȮÀΰ˻ç
antibody producing cell
Ç×ü»ý»ê¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
complement receptor 1
º¸Ã¼ ¼ö¿ëü 1
complement receptor 2
º¸Ã¼¼ö¿ëü 2
complement receptor 3
º¸Ã¼¼ö¿ëü 3
complement receptor 4
º¸Ã¼¼ö¿ëü 4
complement splitting
º¸Ã¼ºÐÇØ(¡ÝÂú°).
complement system
º¸Ã¼°è
complement system
º¸Ã¼°è(¡Í§)
complement system, alternative pathway
´ëü°æ·Î(ÓÛôðÌèÖØ)
complement system, classic pathway
ÀüÇüÀû °æ·Î(îðúþîÜÌèÖØ)
complement typing
º¸Ã¼Çüº°È(úþܬûù)
complement unit
º¸Ã¼´ÜÀ§(¡Ó¤êÈ).
complement-mediated cytotoxicity
º¸Ã¼ °ü·Ã¼º ¼¼Æ÷µ¶¼º(ÜÍô÷μ֤àõ á¬øàÔ¸àõ)
deficiency state, complement
º¸Ã¼°áÇÌÁõ
dominant complement
¿ì¼ºº¸Ã¼(¡ÜÍô÷).
endpiece of complement
º¸Ã¼¸»Àý(ÜÍô÷ØÇï½).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½